Thirty five years ago, we launched Wall Street’s premier investor conference focused exclusively on companies defining the healthcare industry. Today, the J.P. Morgan Healthcare Conference continues our tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2018, CapBridge attended to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting.
Johnson Chen is Founder & CEO of global private capital raising platform CapBridge, which together with secondary trading private exchange platform 1exchange (1X), provide a holistic private capital solution for global growth companies. CapBridge and 1X are formed in partnership with Singapore Exchange (SGX).
With CapBridge and 1X, global growth companies and family businesses can accelerate their growth through intelligent primary capital raises and secure trading of shares, while remaining privately held. CapBridge and 1X provide both growth capital and integrated partial liquidity solutions for private companies and investors alike. This form a comprehensive private markets capital eco-system for deserving companies and sophisticated investors.
An active angel investor and experienced business builder, Johnson has spent over 20 years incubating and steering growth companies. Johnson has founded and listed two companies. He is the Founder and Non-executive Chairman of Clearbridge Health (SGX ticker: 1H3, Bloomberg ticker: CBH.SP), a pan-Asia precision healthcare company. Johnson is also the Founder and Non-executive Director of Biolidics (SGX ticker: 88Y, Bloomberg ticker: BLD.SP), a microfluidic based liquid biopsy tumor diagnosis company. Earlier in his career, Johnson co-founded and successfully exited two tech startups.
Johnson was one of the pioneering team members of Hong Kong based information and incumbent communications technology service company Pacific Century CyberWorks Limited (PCCW). He was subsequently appointed President of CyberWorks Ventures, PCCW’s direct investment arm where he led a team to build up and oversee a multi-million dollar investment portfolio. The youngest member of PCCW’s M&A/investment executive committee at that time, he was responsible for much of PCCW’s strategic expansion, including many of its successful acquisitions and investments.
Johnson sits on the Singapore National Research Foundation Proof-of-Concept grant panel and is a member of the Strategic Research Innovation Fund committee of NTUitive, Nanyang Technological University’s innovation and enterprise company.
As the top graduate in the officer cadet course during his National Service with the Singapore Armed Forces, Johnson was awarded the prestigious Sword of Honour by the President of Singapore.
Johnson holds a Master’s degree and a Bachelor degree in Manufacturing Engineering Tripos (MET) from the University of Cambridge, UK.